Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor
2008 ◽
Vol 49
(1)
◽
pp. 11
◽
Keyword(s):
2004 ◽
Vol 315
(1)
◽
pp. 59-65
◽
2011 ◽
Vol 17
(7)
◽
pp. 601-611
◽